FIELD: chemistry.
SUBSTANCE: invention relates to a stable liquid pharmaceutical composition, which includes 3-(2,2,2-trimethylhydrazinium)propionate-2-ethyl-6-methyl-3-hydroxypyridine disuccinate in amount of 0.1-50 wt %, auxiliary substances in amount of 0.01-50 wt % and water.
EFFECT: invention enables to obtain stable pharmaceutical compositions for injection, peroral and local application, having marked antihypoxic, antioxidant and adaptogenic action.
32 cl, 1 dwg, 14 tbl, 60 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPLEX OF 3-(2,2,2-TRIMETHYLHYDRAZINIUM)PROPIONATE-2-ETHYL-6-METHYL-3-HYDROXYPYRIDINIUM DISUCCINATE POSSESSING ANTIHYPOXIC AND ADAPTOGENIC ACTION, AND METHOD FOR PREPARING IT | 2012 |
|
RU2485953C1 |
| METHOD OF TREATING BODY SYSTEM INVOLVEMENTS CAUSED BY ACTIVATED PEROXIDATION PROCESS AND LIQUID PHARMACEUTICAL COMPOSITION FOR IMPLEMENTATION THEREOF | 2008 |
|
RU2411034C2 |
| SYSTEM FOR DELIVERY OF 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE FOR ORAL ADMINISTRATION IN FORM OF GASTRORETENTIVE TABLET | 2019 |
|
RU2734970C1 |
| N-(3-(5-(4-CHLOROPHENYL)-1N-PYRAZOLO[3,4-B]PYRIDINE-3-CARBONYL)-2,4-DIFLUOROPHENYL)PROPANE-1-SULPHONAMIDE CRYSTALLINE FORM, ACTIVE COMPONENT, PHARMACEUTICAL COMPOSITION AND MEDICINE | 2018 |
|
RU2678455C1 |
| DRUG WITH IMMUNOMODULATORY EFFECT | 2016 |
|
RU2629331C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING VASCULAR DISORDERS AND NEUROPATHIES | 2013 |
|
RU2521199C1 |
| PHARMACEUTICAL COMPOSITIONS BASED ON INDOMETHACIN MENTHYL ETHER AND THEIR APPLICATION AS ANTI-INFLAMMATORY AGENTS | 2017 |
|
RU2685257C1 |
| COMPOSITION FOR TREATMENT OF INFECTIONS OF BACTERIAL ETIOLOGY IN ANIMALS | 2013 |
|
RU2514647C1 |
| MEDICINAL AGENT FOR CARDIOVASCULAR DISEASE TREATMENT AND METHOD OF ITS PREPARING | 1992 |
|
RU2063227C1 |
| PHARMACEUTICAL COMPOSITION FOR INJECTIONS AND METHOD FOR ITS OBTAINING | 2012 |
|
RU2491054C1 |
